Health Related Quality of Life (HRQoL) in Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review (SLR) and Meta-Analysis

被引：0
|
作者：
Banerjee, Rahul [1 ]
Hasegawa, Ken [2 ]
Itani, Taha [2 ]
Giordana, Monique [2 ]
Granados, Enrique [2 ]
Rosado, Margrit B. [3 ]
Chan, Rebecca J. [3 ]
Kostic, Ana [3 ]
Kanters, Steve [4 ]
Zoratti, Michael J. [4 ]
Leleu, Xavier [5 ]
机构：
[1] Fred Hutchinson Canc Ctr, Seattle, WA USA
[2] Kite, Gilead Co, Santa Monica, CA USA
[3] Arcellx Inc, Redwood City, CA USA
[4] RainCity Analyt, Vancouver, BC, Canada
[5] CHU Poitiers, Poitiers, France
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203741
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4721 / 4722
页数：2
相关论文
共 50 条
  • [41] DREAMM-2: Belantamab mafodotin (belamaf; GSK2857916) effect on disease symptoms and health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM)
    Weisel, K.
    Popat, R.
    Lonial, S.
    Lee, H.
    Badros, A.
    Trudel, S.
    Nooka, A.
    Chari, A.
    Abdallah, A-O
    Callander, N.
    Sborov, D.
    Suvannasankha, A.
    Voorhees, P.
    Cohen, A.
    Opalinska, J.
    Gutierrez, B.
    Gorsh, B.
    He, Z.
    Eliason, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 103 - 104
  • [42] Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO.
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Boccadoro, Mario
    Delimpasi, Sosana
    Beksac, Meral
    Katodritou, Eirini
    Moreau, Philippe
    Baldini, Luca
    Symeonidis, Argiris
    Bila, Jelena
    Oriol, Albert
    Mateos, Maria-Victoria
    Einsele, Hermann
    Orfanidis, Ioannis
    Gries, Katharine S.
    Fastenau, John
    Kampfenkel, Tobias
    Qiu, Yanping
    Amin, Himal
    Sonneveld, Pieter
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Assessment of health-related quality of life (HRQoL) in triple-class-exposed patients with relapsed or refractory multiple myeloma (RRMM) treated with linvoseltamab in the LINKER-MM1 trial
    Hoffman, James E.
    Bumma, Naresh
    Richter, Joshua Ryan
    Dhodapkar, Madhav V.
    Lee, Hans C.
    Suvannasankha, Attaya
    Zonder, Jeffrey A.
    Maly, Joseph J.
    Shah, Mansi R.
    Baz, Rachid C.
    DeVeaux, Michelle
    Ivanescu, Cristina
    Rodriguez-Lorenc, Karen
    Kroog, Glenn Scott
    Houvras, Yariv J.
    Inocencio, Timothy J.
    Chi, Lei
    Harnett, James
    Ma, Qiufei
    Jagannath, Sundar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Efficacy and Safety of Daratumumab-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma - A Systematic Literature Review and Network Meta-analysis
    Dimopoulos, Meletios
    Weisel, Katja
    Kaufman, Jonathan L.
    Sonneveld, Pieter
    Rizzo, Maria
    Xu, Yingxin
    Fahrbach, Kyle
    Gaudig, Maren
    Slavcev, Mary
    Lam, Annette
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E63 - E63
  • [45] Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review
    He, Xuepeng
    Yang, Kai
    Chen, Peng
    Liu, Bing
    Zhang, Yuan
    Wang, Fang
    Guo, Zhi
    Liu, Xiaodong
    Lou, Jinxing
    Chen, Huiren
    ONCOTARGETS AND THERAPY, 2014, 7 : 1593 - 1599
  • [46] Estimating the Relative Effectiveness of Treatments in Relapsed/Refractory Multiple Myeloma through a Systematic Review and Network Meta-Analysis
    Ruggeri, Kai
    Maguire, Aine
    Schmitz, Susanne
    Haller, Elisa
    Walsh, Cathal
    Bowden, Jack
    Kuhn, Isla
    Khan, Ayesha
    Cook, Gordon
    O'Dwyer, Michael
    BLOOD, 2015, 126 (23)
  • [47] Systematic review and meta-analysis of the efficacy and safety of novel monoclonal antibodies for treatment of relapsed/refractory multiple myeloma
    Zhang, Tiantian
    Wang, Sen
    Lin, Tengfei
    Xie, Jingmei
    Zhao, Lina
    Liang, Zhuoru
    Li, Yangqiu
    Jiang, Jie
    ONCOTARGET, 2017, 8 (20) : 34001 - 34017
  • [48] Sarcopenia and health-related quality of life: A systematic review and meta-analysis
    Beaudart, Charlotte
    Demonceau, Celine
    Reginster, Jean-Yves
    Locquet, Medea
    Cesari, Matteo
    Cruz Jentoft, Alfonso J.
    Bruyere, Olivier
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, 14 (03) : 1228 - 1243
  • [49] HEALTH-RELATED QUALITY OF LIFE IN NARCOLEPSY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Tadrous, Ragy
    O'Rourke, Deirdre
    Broderick, Julie
    Mockler, David
    SLEEP, 2021, 44 : A200 - A200
  • [50] HEALTH-RELATED QUALITY OF LIFE IN SARCOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Beaudart, C.
    Demonceau, C.
    Reginster, J. -Y.
    Locquet, M.
    Cesari, M.
    Jentoft, A. J. Cruz
    Bruyere, O.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S58 - S59
12345